Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,760
datasets available to search
ShareScore release 0.9.0
Dataset results
1,760 results for “phase 2”
A Phase 2, Multicenter Open-Label Extension (OLE) Study With ABT-122 in Active Psoriatic Arthritis Subjects Who Have Completed a Preceding Study M14-197
ClinicalTrials.gov study NCT02429895. IPD Sharing: Not stated. Countries: 10. Publications: 1.
Human Recombinant Interferon Gamma-1b for the Prevention of Hospital-acquired Pneumonia in Critically Ill Patients: a Double-blind, International, Phase 2, Randomized, Placebo-controlled Trial - the P
ClinicalTrials.gov study NCT04793568. IPD Sharing: Not stated. Countries: 3. Publications: 4.
Malaysian COVID-19 Anosmia Study (Phase 2) - A Nationwide Multicentre Case-Control Study
ClinicalTrials.gov study NCT04384042. IPD Sharing: NO. Countries: 1. Publications: 7.
Brief Behavioral Treatment of Insomnia in Military Veterans: Phase 2 (BBTIMVII)
ClinicalTrials.gov study NCT00840255. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ASP1517 Phase 2 Clinical Trial - Double-Blind Study of ASP1517 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis-
ClinicalTrials.gov study NCT01964196. IPD Sharing: YES. Countries: 1. Publications: 2.
A Phase 2 Study to Explore the Dose of HCP1803 in Patients With Essential Hypertension
ClinicalTrials.gov study NCT04959305. IPD Sharing: NO. Countries: 1. Publications: 1.
A Phase 3 STudy of CaPRe in LOwering Very hiGh TriglYcerides (TRILOGY 2)
ClinicalTrials.gov study NCT03361501. IPD Sharing: NO. Countries: 3. Publications: 1.
OBE001 Phase 2 Dose-finding Study Versus Placebo in Women Undergoing Embryo Transfer in the Context of IVF-ICSI
ClinicalTrials.gov study NCT02310802. IPD Sharing: Not stated. Countries: 6. Publications: 1.
AMG 386 Phase 2 Open-Label Renal Cell Carcinoma (RCC) Study 1st Line or After Cytokine Failure in Combination With Sunitinib
ClinicalTrials.gov study NCT00853372. IPD Sharing: YES. Countries: 0. Publications: 1.
Prospective Analysis of Morbi-mortality of Patients With Cancers in Active Phase of Treatment Suspected or Diagnosed of a SARS-CoV-2 Infection
ClinicalTrials.gov study NCT04363632. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase 2 Study of CDX-0159 in Patients With Chronic Spontaneous Urticaria
ClinicalTrials.gov study NCT05368285. IPD Sharing: Not stated. Countries: 9. Publications: 0.
Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis
ClinicalTrials.gov study NCT04163419. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced Cancer
ClinicalTrials.gov study NCT01187199. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Allogeneic or Autologous γδ T Cells (DeltEx) in Combination With Maintenance Temozolomide in Subjects With Recurrent or Newly
ClinicalTrials.gov study NCT05664243. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study
ClinicalTrials.gov study NCT06594393. IPD Sharing: Not stated. Countries: 4. Publications: 1.
A Phase 2 Clinical Study of KHK4827
ClinicalTrials.gov study NCT01748539. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Early Phase Human Drug Trial to Investigate DYN101 in Participants 2 to 17 Years With Centronuclear Myopathies
ClinicalTrials.gov study NCT04743557. IPD Sharing: NO. Countries: 2. Publications: 1.
A Phase II/III Study of PIKA Recombinant SARS-CoV-2 Vaccine as a Booster Dose.
ClinicalTrials.gov study NCT05463419. IPD Sharing: NO. Countries: 2. Publications: 1.
A Phase I Clinical Trial to Evaluate: Part A. The Safety of MTP-PE/MF59 Adjuvant Emulsion. Part B. The Safety and Immunogenicity of Env 2-3, a Yeast Derived Recombinant Envelope Protein of Human Immun
ClinicalTrials.gov study NCT00000972. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Phase II Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19
ClinicalTrials.gov study NCT04990544. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.